Back to Search
Start Over
Street Cheers ImClone, but Analysts Remain Wary; The stock gained amid word of a fresh tussle between the drug outfit's board and Carl Icahn, who refused to support a $36 a share buyout bid
- Source :
- Business Week Online. Oct 5, 2006
- Publication Year :
- 2006
- Subjects :
- Diagnostic reagents industry -- Securities
Diagnostic reagents industry -- Company forecasts
Diagnostic reagents industry -- Management
Company securities
Company business forecast/projection
Company business management
ImClone Systems Inc. -- Securities
ImClone Systems Inc. -- Company forecasts
ImClone Systems Inc. -- Management
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Week Online
- Publication Type :
- Periodical
- Accession number :
- edsgcl.152385527